Nasdaq
$0.9894▲ 0.50%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.1MShares out 1.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
33- 6d agoPre-market26.10.19 13:15filedEFFECTOther#●●●#●●●
Decoy Therapeutics Inc.
Decoy Therapeutics Inc. received official notice from the SEC that its registration statement became effective as of October 16, 2026. This approval authorizes the company to proceed with the issuance or sale of the registered securities.…more
$0.9894+0.50%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16After-hours26.10.17 05:07424B3Offering
Decoy Therapeutics Inc.
Decoy Therapeutics filed this prospectus to register the resale of up to 2,368,868 shares of common stock issuable upon the exercise of new warrants issued in a private placement on September 23, 2026. While the company held $8.0 million in cash as of September 30, 2026, it faces substantial doubt regarding its ability to continue as a going concern. The potential exercise of these warrants at $3.25 per share provides uncertain funding, and the registration of these shares poses significant dilution risks to existing shareholders.…more
$0.9894+0.50%vs prev closeView filingShare - 10.7After-hours26.10.08 05:59S-1Offering
Decoy Therapeutics Inc.
Decoy Therapeutics has filed an S-1 registration statement for the resale of up to 2,368,868 shares of common stock issuable upon the exercise of new warrants issued in a private placement that closed on September 23, 2026. The company will not receive proceeds from the resale of these shares by the selling stockholder.…more
$0.9894+0.50%vs prev closeView filingShare
32 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.7After-hours26.10.08 06:07Bullish#●●●
Decoy Therapeutics Files Prospectus for Resale of Up to 2.37 Million Shares…more
Decoy Therapeutics has filed a prospectus with the SEC for the potential resale of up to 2,368,868 common shares. This filing relates to the resale of shares by existing holders, which may lead to potential dilution.…more
$0.9894+0.50%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.30Pre-market26.09.30 21:30
●●●●●●●● ●●●●● ●●●●●●
Decoy Therapeutics will participate in The Small Cap Showcase in New York to deliver a corporate presentation and hold investor meetings. As this is a standard investor relations event without specific new business deals or financial results, the impact on the stock price is expected to be neutral.…more
$0.9894+0.50%vs prev close - 9.29Pre-market26.09.29 20:32
●●●●●●●● ●●●●● ●●●●●●
Decoy Therapeutics announced that preclinical data for its intranasal drug DCOY-CoV shows drug levels are maintained for up to 7 days after a single dose. The company plans to initiate clinical trials in 2027.…more
$0.9894+0.50%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report